Responses
Diabetes and endocrinology
Research
Examining the risk of depression or self-harm associated with incretin-based therapies used to manage hyperglycaemia in patients with type 2 diabetes: a cohort study using the UK Clinical Practice Research Datalink
Compose a Response to This Article
Other responses
No responses have been published for this article.